Targetjng Global Leadership in Decentralised Water & Wastewater - - PowerPoint PPT Presentation
www.fmuencecorp.com Targetjng Global Leadership in Decentralised Water & Wastewater Treatment Solutjons Annual General Meetjng 22 May 2019 Agenda 1. Chairmans Address Richard Irving 2. Managing Directors Presentatjon Henry
www.fmuencecorp.com
5
6
($ millions) 2017(1) 2018(2) Revenue 58.0 101.1 Gross Profjt Margin 13.0 34.5 Gross Profjt Margin 22% 34% EBITDA
(1) 2017 pro-forma (consolidatjon of 12 months of RWL water) (2) Q4 and Full Year Audited Gross Profjt include a $6.5M benefjt of reversal of an onerous contract provision from prior years
US$M US$M
$0 $10 $20 $30 $40 $50 Q1 Q2 Q3 Q4
Revenue
2017 2018 2019 $0 $50 $100 $150 $200 $250 $300 Q1 Q2 Q3 Q4
Backlog
2017 2018 2019
7
FY 2019E
revenue growth of Smart Products
projects with Recurring Revenue
positjve EBITDA Q1 2018
Decentralized Water & Wastewater Company of the Year
and Philippines Q3 2018
ITEST
signed in Philippines
Aspiral™ sales in US and Philippines Q3 2017 Emefcy and RWL Water merged to form Fluence Corporatjon (ASX:FLC) Q4 2017 Opening of fjrst MABR manufacturing plant in Changzhou, China Q1 2019
Record quarterly bookings of
$223M
Awarded €165M landmark Ivory
Coast contract
Largest individual order of 40
Aspiral™ units in China
Offjcial launch of SUBRE and fjrst
commercial orders secured
Revenue of $12.3M, up 20% YoY Total backlog of $267M, up 181%
YoY
2019 guidance reaffjrmed
Q2 2018
reaches Financial Close
suite launch Q4 2018
San Quintjn Project
(12 units)
$50M Generate Capital debt facility FY 2018
revenue growth of 74%
Gross Profjt
30%
8
Custom Engineered Solutjons
Water Treatment Desalinatjon Reuse Wastewater Treatment Wastewater-to- Energy Food & Beverage Processing
9
facility of US$2m for project in Bimini, Bahamas
Bahamas, Peru and San Quintjn
market
industrial customer
10
Water and wastewater treatment solutions for customers across the industrial, commercial and municipal sectors Water and wastewater treatment solutions for customers across the industrial, commercial and municipal sectors
Smart Products Solutions Recurring Revenue and Aftermarket Services Custom-Engineered Solutions Aspiral, SUBRE, NIROBOX BOOT Complete range of O&M and Aftermarket offerings Waste-to-Energy, Large projects, EPC
Reportjng Segment Products
11
Market Drivers: Market Adoptjon:
Packaged MABR wastewater treatment solutjons Stricter regulatjons Decentralizatjon, Energy effjciency Increased urbanizatjon, New-build infrastructure 5,000-200,000 GPD raw municipal sewage Plants USVI, Stanford (Title 22 validated), Oregon, Texas, Argentjna, Ecuador, China, Philippines, Israel Packaged potable water treatment solutjons Water shortages Decentralizatjon, Energy-effjciency Increased urbanizatjon, New-build infrastructure 130,000-400,000 GPD Seawater, Fresh water, Brackish water Plants globally including Egypt, South Africa, Philippines, Caribbean, Mexico, South America MABR wastewater treatment solutjons for existjng or new plants Stricter regulatjons Process intensifjcatjon Outdated infrastructure Energy effjciency 0.15-25 MGD raw municipal sewage Ma’ayan Zvi, Israel Signifjcant and growing pipeline Commercial launch Q1 2019 and fjrst commercial orders in Jamaica
12
Wastewater Treatment Water Treatment
Complete Water and Wastewater Solutions Recurring High Margin Revenue
Capex
Multi-year Recurring Revenue
ideal for BOOT projects Footprint, energy efficiency, reliability, low maintenance and quality output Using in-house proprietary technologies enhances margin
solutions
revenue for many years with higher valuations
13
Government of Ivory Coast, signed in February 2019
solutjon for 150,000 m3/day surface-water treatment plant
potable water to the city of Abidjan (4.7M populatjon)
bulk water piping, water towers and infrastructure
Credit Agency (ASHRA, Israel) and fjnanced through Israel Discount Bank
expected by Q3 2019
Water from Lagune Aghien will be treated to supply potable water for Abidjan CAD depictjon of plant locatjon and layout
14
Custom-Engineered Solutjons Large projects Wastewater-to-energy Water purifjcatjon Smart Products Solutjons Aspiral, NIROBOX, SUBRE 2018: $22M 2019 target: $44M Recurring Revenue BOOT projects, Afuermarket
2018 Future Target Revenue Mix 2017
Shifu towards higher margin proprietary solutjons and recurring revenues Shifu towards higher margin proprietary solutjons and recurring revenues
$58M $101M
15
Increasing Gross Margin Large Project Smart Packaged Plant Proprietary Smart Packaged Plant Proprietary Product
>EUR165M (Ivory Coast project) NIROBOX™ Aspiral™ SUBRE Example:
16
Products from $22M to $44M
Recurring Revenue
Q4 2019
SUBRE installatjon, Ma’ayan Zvi, Israel Fluence MABR manufacturing plant, Changzhou, China
18
This presentatjon has been prepared by Fluence Corporatjon Limited (ASX: FLC). All currencies quoted as “$” are US$ unless otherwise specifjed. This presentatjon may contain forward-looking statements which are identjfjed by words such as ‘may’, ‘could’, ‘believes’, ‘estjmates’, ‘targets’, ‘expects’, or ‘intends’ and other similar words that involve risks and uncertaintjes. These statements are based on an assessment of past and present economic and
Such forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertaintjes, assumptjons and other important factors many of which are beyond the control of the Company, its Directors and management. Although the Company believes that the expectatjons refmected in and the assumptjons underlying the forward looking statements included in this presentatjon are reasonable, readers are cautjoned not to place undue reliance on them, as the Company cannot give any assurance that the results, performance or achievements covered by the forward-looking statements will actually occur. This presentatjon should not be considered as an ofger or invitatjon to subscribe for or purchase any shares in FLC or as an inducement to make an ofger or invitatjon to subscribe for or purchase any shares in FLC. No agreement to subscribe for securitjes in the FLC will be entered into on the basis of this presentatjon or any informatjon, opinions or conclusions expressed in the course of this presentatjon. This presentatjon is not a prospectus, product disclosure document or other ofgering document under Australian law or under the law of any other jurisdictjon. It has been prepared for informatjon purposes only and does not constjtute an ofger or invitatjon to apply for any securitjes, including in any jurisdictjon where, or to any person to whom, such an ofger or invitatjon would be unlawful. To the maximum extent permitued by law, the Company and its professional advisors and their related bodies corporate, affjliates and each of their respectjve directors, offjcers, management, employees, advisers and agents and any other person involved in the preparatjon of this presentatjon disclaim all liability and responsibility (including without limitatjon and liability arising from fault or negligence) for any direct or indirect loss or damage which may arise or be sufgered through use of or reliance on anything contained in, or omitued from, this presentatjon. Neither the Company nor its advisors have any responsibility or
may afgect any matuer referred to in the presentatjon. Readers should make their own independent assessment of the informatjon and take their own independent professional advice in relatjon to the informatjon and any proposed actjon to be taken on the basis of the informatjon. 2018 consolidated fjnancial fjgures presented on IFRS basis are audited, and afuer reclassifjcatjons for non-cash foreign currency adjustment relatjng to hyperinfmatjon accountjng in Argentjna (IAS29).
19
Adam Hinckley VP Investor Relatjons & Project Finance +1 914 998 3304 ahinckley@fmuencecorp.com Henry Charrabé Managing Director & CEO +1 212 572 3766 hcharrabe@fmuencecorp.com
Gary Dvorchak The Blueshirt Group +1 323 240 5796 +86 138 1079 1480 gary@blueshirtgroup.com Ronn Bechler Market Eye +61 400 009 774 Ronn.Bechler@marketeye.com.au